Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-04-19
2005-04-19
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
06881721
ABSTRACT:
The present invention provides a pharmaceutical composition for treatment and prevention of hemorrhage associated with blood coagulation disorders, comprising activated Factor VII (FVIIa) and Factor X (FX) as an active ingredient. The pharmaceutical composition of the present invention contains no components causative side effects, is safe, highly efficacious, and easy to manage hemostasis. The pharmaceutical composition can be used for hemostatic management of patients suffering from hemorrhage associated with blood coagulation disorders, for example, disorders (including deficiency) of blood coagulation factors, especially caused by inhibitors (antibodies) against blood coagulation factors.
REFERENCES:
patent: 4286056 (1981-08-01), Andary et al.
patent: 4287180 (1981-09-01), Thomas
patent: 4357321 (1982-11-01), Thomas
patent: 4459288 (1984-07-01), Thomas
patent: 4663164 (1987-05-01), Thomas
patent: 5891843 (1999-04-01), Turecek et al.
patent: 6083905 (2000-07-01), Voorberg et al.
patent: 651054 (1995-05-01), None
patent: 765669 (1997-02-01), None
patent: 3-155797 (1991-07-01), None
patent: 7-145072 (1995-06-01), None
patent: 7-145073 (1995-06-01), None
patent: 7-145074 (1995-06-01), None
patent: 7-145075 (1995-06-01), None
patent: 10-59866 (1998-03-01), None
patent: 10-59867 (1998-03-01), None
Y. Sultan et al.; Thrombosis and Haemostasis; vol. 67(6), pp. 600-602; 1992.
S. Ehrenforth et al.; The Lancet; vol. 339, pp. 594-598, 1992.
G. L. Bray et al.; Blood, vol. 83, No. 9, May 1, 1994, pp. 2428-2435.
David Green et al.; Thrombos. Haemostas.; vol. 45(3), pp. 200-203, 1981.
Stephen Chavin et al.; The American Journal of Medicine; vol. 85, pp. 245-249, 1988.
Thromb. Haemost.; vol. 48(3), pp. 339-340, 1982.
Ulla Hedner et al.; Transfusion Medicine Reviews, vol. VII, No. 2, Apr. 1993, pp. 78-83.
Hidehiko Saito et al.; Jpn. J. Thromb. Hemost., vol. 5(3), pp. 158-172, 1994.
D.S.C Telgt et al.; Thrombosis Research, vol. 56, pp. 603-609, 1989.
Haemostasis; vol. 26, (Supp. 1); pp. 143-149, 1996.
Kamiya T. et al., International Journal of Hematology, 1995, vol. 62, No. 3, pp. 175-181.
D.M. Monroe et al.; Blood Coagulation & Fibrinolysis, vol. 9, No. SUPPL 1, 1998, pp. S15-S-20.
G.A. Allen et al.; Blood Coagulation and Fibrinolysis, vol. 11, No. Supplement 1, Apr. 2000, pp. S3-S7. (After Priority Date).
K. Tomokiyo et al.; Vox Sanguinis, vol. 85, No. 4, Nov. 2003, pp. 290-299. (After Priority Date).
Araki Tatsuya
Nakagaki Tomohiro
Nakatomi Yasushi
Teshima Kaori
Tomokiyo Kazuhiko
Audet Maury
Birch & Stewart Kolasch & Birch, LLP
Juridical Foundation the Chemo-Sero-Therapeutic Research Institu
Tate Christopher R.
LandOfFree
Medicinal compositions for treating and preventing diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal compositions for treating and preventing diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal compositions for treating and preventing diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3387258